In its first-quarter 2025 investor letter, Diamond Hill Large Cap Fund highlighted stocks such as Abbott Laboratories (NYSE:ABT). Abbott Laboratories (NYSE:ABT) is a leading manufacturer of health ...

Given the large stake in the stock by institutions, Abbott Laboratories' stock price might be vulnerable to their trading decisions The top 25 shareholders own 49% of the company We've found 21 US ...

In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Abbott Laboratories (NYSE:ABT). Abbott Laboratories (NYSE:ABT) is a leading manufacturer of health ...

Abbott Laboratories (ABT) shares fell 0.4%, after a jury ordered the Illinois-based company to pay $495 million in a product-liability lawsuit. The jury determined Friday that the maker of Similac ...

In a win for Abbott Laboratories, a federal judge in Chicago sided with the company Friday in the case of a woman who alleged that Abbott’s formula for preterm infants led to her daughter’s death.

Profit margin: 13% (in line with 1Q 2024). EPS: US$0.76 (up from US$0.70 in 1Q 2024). We've discovered 1 warning sign about Abbott Laboratories. View them for free. Revenue was in line with analyst ...

A judge threw out one the first "bellwether" federal lawsuits against Abbott Laboratories and its competitor, Mead Johnson, over the safety of their preterm baby formulas. U.S. District Court ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...